Response
Dr Urbanski raises an important issue related to the appropriate therapy of type A aortic intramural hematoma (IMH). However, our study was focused on the long-term evolution and morphological changes of IMH showing the frequent evolution to aneurysm or pseudoaneurysm (54%), particularly in the descending aorta. 1 As in our series, type A IMH was limited to 12 patients; such a small number would not have permitted any conclusion related to type A IMH therapy to be drawn.
No general consensus exists on the appropriate treatment of ascending aorta IMH. Some groups believe that the therapeutic strategy for IMH should be the same as that for aortic dissection. In a meta-analysis, 2 mortality of type A IMH treated medically was high, 56%. However, Asian series [3] [4] [5] showed low death rates in proximal IMH treated medically (6% to 10%). Song et al 5 reported that 64% of medically treated type A IMH evolved without complications; most of them exhibited complete IMH resorption. The evolution of type A IMH appears to be more benign than that of classical dissection. Kaji et al 4 showed that medical therapy with timed surgical repair in cases with progression can also be a rational therapeutic strategy. Several factors such as maximum aortic diameter, IMH thickness, age, and pericardial or periaortic blood extravasation have been related to poor outcomes. [1] [2] [3] [4] [5] Studies are required to verify the benefit of emergency surgery in patients without these poor prognostic factors compared with repeated imaging monitoring, with surgery being indicated in complicated cases.
None of these issues is addressed in our study, which is mainly descriptive in character. 
